(2alpha,5alpha,17beta)-17-Hydroxy-2,17-dimethylandrostan-3-one(CAS: 3381-88-2)

This compound falls under various regulatory guidelines including GHS classification for hazardous substances, REACH regulations for the European Union, and FDA and EPA requirements for handling and use. Special attention should be given to its potential for hormonal effects and reproductive toxicity.

Alternatives to this compound include other steroid hormones and their derivatives. Common substitutes in synthesis include androstenedione and other 17-hydroxy-androstanes, which can serve similar roles in synthetic processes.

Market trends suggest ongoing research into the use of this compound in hormone replacement therapies and as an intermediary in steroid synthesis. However, due to safety concerns, there is a growing emphasis on developing less potent analogs and safer alternatives.

Waste containing this compound should be managed according to hazardous waste disposal guidelines. This includes proper collection, neutralization if necessary, and incineration or professional waste disposal to prevent environmental contamination and ensure worker safety.